We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$244B
AUM Growth
+$28.7B
Cap. Flow
+$16.9B
Cap. Flow %
6.95%
Top 10 Hldgs %
15.69%
Holding
4,180
New
139
Increased
3,365
Reduced
234
Closed
111

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$465M
2
MSFT icon
Microsoft
MSFT
+$373M
3
AMZN icon
Amazon
AMZN
+$274M
4
XOM icon
ExxonMobil
XOM
+$253M
5
META icon
Meta Platforms (Facebook)
META
+$251M

Sector Composition

Rank Sector Weight
1 Technology 15.77%
2 Financials 15.74%
3 Healthcare 13.31%
4 Industrials 10.5%
5 Consumer Discretionary 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRFS
3701
DELISTED
BRF SA
BRFS
$141K ﹤0.01%
11,587
SUMR
3702
DELISTED
Summer Infant, Inc.
SUMR
$141K ﹤0.01%
8,279
+42
+0.5% +$730
AQB icon
3703
AquaBounty Technologies
AQB
$6.02M
$140K ﹤0.01%
+635
New +$178K
FRD icon
3704
Friedman Industries
FRD
$317M
$140K ﹤0.01%
21,701
REFR icon
3705
Research Frontiers
REFR
$17M
$139K ﹤0.01%
99,765
+516
+0.5% +$888
CXDC
3706
DELISTED
China XD Plastics Company Limited
CXDC
$139K ﹤0.01%
28,383
+8,277
+41% +$36.4K
NBRV
3707
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$139K ﹤0.01%
+46
New +$112K
DVCR
3708
DELISTED
Diversicare Healthcare Services Inc
DVCR
$139K ﹤0.01%
13,755
BNBX
3709
DELISTED
BNB PLUS CORP
BNBX
0
PULM icon
3710
Pulmatrix
PULM
$6.06M
$138K ﹤0.01%
+199
New +$118K
PTX
3711
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$138K ﹤0.01%
37,395
+72
+0.2% +$226
ICLN icon
3712
iShares Global Clean Energy ETF
ICLN
$2.1B
0
INUV icon
3713
Inuvo
INUV
$17M
$137K ﹤0.01%
10,685
SUNE
3714
SUNation Energy
SUNE
$10.8M
0
HTGM
3715
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$137K ﹤0.01%
110
QBAK
3716
DELISTED
Qualstar Corp
QBAK
$137K ﹤0.01%
25,985
TAT
3717
DELISTED
TransAtlantic Petroleum LTD.
TAT
$137K ﹤0.01%
97,946
TA
3718
DELISTED
TravelCenters of America LLC
TA
$136K ﹤0.01%
4,481
+155
+4% +$5.23K
LEU icon
3719
Centrus Energy
LEU
$3.82B
$134K ﹤0.01%
22,164
ECF
3720
Ellsworth Growth & Income Fund
ECF
$172M
$133K ﹤0.01%
15,447
FTEK icon
3721
Fuel Tech
FTEK
$43.7M
$131K ﹤0.01%
129,368
+384
+0.3% +$450
GMO
3722
DELISTED
General Moly, Inc.
GMO
$131K ﹤0.01%
263,354
IMNP
3723
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$130K ﹤0.01%
44,707
+22,354
+100% +$80.7K
XIN
3724
DELISTED
Xinyuan Real Estate
XIN
$129K ﹤0.01%
2,937
-2,294
-44% -$115K
CFRX
3725
DELISTED
ContraFect Corporation
CFRX
$129K ﹤0.01%
90
+1
+1% +$1.57K

Similar funds

Geode Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Geode Capital Management held 4,180 positions worth $244B, up 13% from $215B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Geode Capital Management deployed $16.9B of net new capital in Q1 2017, opening 139 new positions and adding to 3,365 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Computer Sciences, an estimated $56.7M trimmed.

  • Geode Capital Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
  • Geode Capital Management added most to Apple in Q1 2017, an estimated $465M increase.
  • Geode Capital Management's biggest Q1 2017 reduction was Computer Sciences, cutting an estimated $56.7M.
  • Geode Capital Management fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $249M.
  • Geode Capital Management's ten largest holdings make up 16% of its $244B portfolio in Q1 2017.
  • Geode Capital Management opened 139 new positions and closed 111 in Q1 2017.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $244B.

Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.